{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:15:24Z","timestamp":1790262924521,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":196,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.14283\/jpad.2024.26","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T03:11:05Z","timestamp":1705633865000},"page":"428-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Nanolithium, a New Treatment Approach to Alzheimer's Disease: A Review of Existing Evidence and Clinical Perspectives"],"prefix":"10.1016","volume":"11","author":[{"given":"Solene","family":"Guilliot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.N.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Touchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2024.26_bib1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/mp.2015.4","article-title":"Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics","volume":"20","author":"Alda","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.14283\/jpad.2024.26_bib2","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-230568","article-title":"Lithium, a Treatment Option for Alzheimer's Disease? A Review of Existing Evidence and Discussion on Future Perspectives","author":"Guilliot","year":"2023","journal-title":"J Alzheimers Dis JAD"},{"key":"10.14283\/jpad.2024.26_bib3","first-page":"104","article-title":"Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease","volume":"10","author":"Nunes","year":"2013","journal-title":"Curr Alzheimer Res"},{"key":"10.14283\/jpad.2024.26_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-150437","article-title":"Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis","volume":"48","author":"Matsunaga","year":"2015","journal-title":"J Alzheimers Dis JAD"},{"key":"10.14283\/jpad.2024.26_bib5","unstructured":"FDA Highlights of prescribing information: Lithium Carbonate."},{"key":"10.14283\/jpad.2024.26_bib6","unstructured":"FDA Highlights of prescribing information: LITHOBID\u00ae."},{"key":"10.14283\/jpad.2024.26_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21307\/ane-2017-001","article-title":"Lithium - therapeutic tool endowed with multiple beneficiary effects caused by multiple mechanisms","volume":"76","author":"Vosahlikova","year":"2016","journal-title":"Acta Neurobiol Exp (Warsz)"},{"key":"10.14283\/jpad.2024.26_bib8","first-page":"207","article-title":"Molecular origin of Na(+)\/Li(+) exchanger: Evidence against the involvement of major cloned erythrocyte transporters","volume":"18","author":"Koltsova","year":"2011","journal-title":"Pathophysiol Off J Int Soc Pathophysiol"},{"key":"10.14283\/jpad.2024.26_bib9","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/nbm.2929","article-title":"Lithium Compartmentation in Brain by 7Li MRS: Effect of Total Lithium Concentration","volume":"26","author":"Komoroski","year":"2013","journal-title":"NMR Biomed"},{"key":"10.14283\/jpad.2024.26_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40345-016-0068-y","article-title":"Lithium side effects and toxicity: prevalence and management strategies","volume":"4","author":"Gitlin","year":"2016","journal-title":"Int J Bipolar Disord"},{"key":"10.14283\/jpad.2024.26_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcis.2013.10.058","article-title":"Phase behavior of reverse microemulsions based on Peceol(\u00ae)","volume":"416","author":"Mouri","year":"2014","journal-title":"J Colloid Interface Sci"},{"key":"10.14283\/jpad.2024.26_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jcis.2015.06.010","article-title":"Development of pharmaceutical clear gel based on Peceol\u00ae, lecithin, ethanol and water: Physicochemical characterization and stability study","volume":"457","author":"Mouri","year":"2015","journal-title":"J Colloid Interface Sci"},{"key":"10.14283\/jpad.2024.26_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijpharm.2014.07.018","article-title":"Water solubilization capacity of pharmaceutical microemulsions based on Peceol\u00ae, lecithin and ethanol","volume":"475","author":"Mouri","year":"2014","journal-title":"Int J Pharm"},{"key":"10.14283\/jpad.2024.26_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpharm.2016.01.072","article-title":"Formulation, physicochemical characterization and stability study of lithium-loaded microemulsion system","volume":"502","author":"Mouri","year":"2016","journal-title":"Int J Pharm"},{"key":"10.14283\/jpad.2024.26_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/CIRCRESAHA.112.280081","article-title":"Scavenger Receptor Class B Type I (SR-BI) is a Plasma Membrane Cholesterol Sensor","volume":"112","author":"Saddar","year":"2013","journal-title":"Circ Res"},{"key":"10.14283\/jpad.2024.26_bib16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2004.02373.x","article-title":"Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model","volume":"89","author":"Balazs","year":"2004","journal-title":"J Neurochem"},{"key":"10.14283\/jpad.2024.26_bib17","doi-asserted-by":"crossref","first-page":"e0142267","DOI":"10.1371\/journal.pone.0142267","article-title":"Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease","volume":"10","author":"Nunes","year":"2015","journal-title":"PloS One"},{"key":"10.14283\/jpad.2024.26_bib18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/bdi.12449","article-title":"Long-term lithium treatment increases intracellular and extracellular brain-derived neurotrophic factor (BDNF) in cortical and hippocampal neurons at subtherapeutic concentrations","volume":"18","author":"De-Paula","year":"2016","journal-title":"Bipolar Disord"},{"key":"10.14283\/jpad.2024.26_bib19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3233\/JAD-2011-101875","article-title":"Long-term treatment with lithium alleviates memory deficits and reduces amyloid-\u03b2 production in an aged Alzheimer's disease transgenic mouse model","volume":"24","author":"Zhang","year":"2011","journal-title":"J Alzheimers Dis JAD"},{"key":"10.14283\/jpad.2024.26_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/JAD-2010-1349","article-title":"A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment","volume":"20","author":"Leon","year":"2010","journal-title":"J Alzheimers Dis JAD"},{"key":"10.14283\/jpad.2024.26_bib21","doi-asserted-by":"crossref","first-page":"e1190","DOI":"10.1038\/tp.2017.169","article-title":"BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early stage amyloid neuropathology","volume":"7","author":"Wilson","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.14283\/jpad.2024.26_bib22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","article-title":"Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production","volume":"360","author":"Citron","year":"1992","journal-title":"Nature"},{"key":"10.14283\/jpad.2024.26_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.14283\/jpad.2024.26_bib24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3233\/JAD-190862","article-title":"NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats","volume":"73","author":"Wilson","year":"2020","journal-title":"J Alzheimers Dis JAD"},{"key":"10.14283\/jpad.2024.26_bib25","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2174\/1567205015666180904154446","article-title":"Microdose Lithium NP03 Diminishes Pre-Plaque Oxidative Damage and Neuroinflammation in a Rat Model of Alzheimer's-like Amyloidosis","volume":"15","author":"Wilson","year":"2018","journal-title":"Curr Alzheimer Res"},{"key":"10.14283\/jpad.2024.26_bib26","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1084\/jem.20021546","article-title":"CD36 mediates the innate host response to beta-amyloid","volume":"197","author":"El Khoury","year":"2003","journal-title":"J Exp Med"},{"key":"10.14283\/jpad.2024.26_bib27","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.14283\/jpad.2024.26_bib28","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1038\/s41598-017-09239-5","article-title":"In vivo regulation of glycogen synthase kinase 3\u03b2 activity in neurons and brains","volume":"7","author":"Krishnankutty","year":"2017","journal-title":"Sci Rep"},{"key":"10.14283\/jpad.2024.26_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1146\/annurev.pharmtox.41.1.789","article-title":"Molecular targets of lithium action","volume":"41","author":"Phiel","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.14283\/jpad.2024.26_bib30","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.nbd.2012.06.026","article-title":"NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease","volume":"48","author":"Pouladi","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.14283\/jpad.2024.26_bib31","first-page":"1501","article-title":"Intraneuronal Amyloid Beta Accumulation Disrupts Hippocampal CRTC1-Dependent Gene Expression and Cognitive Function in a Rat Model of Alzheimer Disease","volume":"27","author":"Wilson","year":"2017","journal-title":"Cereb Cortex N Y N"},{"key":"10.14283\/jpad.2024.26_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cellsig.2012.09.016","article-title":"Lithium enhances CRTC oligomer formation and the interaction between the CREB coactivators CRTC and CBP \u2014 Implications for CREB-dependent gene transcription","volume":"25","author":"Heinrich","year":"2013","journal-title":"Cell Signal"},{"key":"10.14283\/jpad.2024.26_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1515\/REVNEURO.2007.18.2.93","article-title":"Adult hippocampal neurogenesis, synaptic plasticity and memory: facts and hypotheses","volume":"18","author":"Bruel-Jungerman","year":"2007","journal-title":"Rev Neurosci"},{"key":"10.14283\/jpad.2024.26_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.expneurol.2006.09.018","article-title":"Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease","volume":"204","author":"Zhang","year":"2007","journal-title":"Exp Neurol"},{"key":"10.14283\/jpad.2024.26_bib35","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1126\/science.1088417","article-title":"Inflammatory blockade restores adult hippocampal neurogenesis","volume":"302","author":"Monje","year":"2003","journal-title":"Science"},{"key":"10.14283\/jpad.2024.26_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/NEN.0b013e31816a1df3","article-title":"Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease","volume":"67","author":"Geula","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.14283\/jpad.2024.26_bib37","unstructured":"Erickson C, Chin N, Rosario H, Peterson A, Johnson S, Raket LL, Cummings J, Starling S, Munoz G, Evans M, Engler J, Rutrick S, Maheux E, Koval I, Ortholand J, Birkenbihl C, Bouteloup V, Abdelnour C, Toledo JB, Ferreira D, Rodr\u00edguez-Porcel F, Choudhury P, Okafor M, Scholz S, Boeve B, Litvan I, Leverenz J, Bonanni L, Taylor J-P, Lewis SJG, Aarsland D, Poston K Theme: Clinical Trials: Methodology."},{"key":"10.14283\/jpad.2024.26_bib38","unstructured":"Clinical Safety and Efficacy Evaluation of NanoLithium\u00ae NP03 in Patients With Mild-to-severe Alzheimer's Disease - Full Text View - ClinicalTrials.gov."},{"key":"10.14283\/jpad.2024.26_bib39","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.14283\/jpad.2024.26_bib40","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/alz.12335","article-title":"Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria","volume":"17","author":"De Mauleon","year":"2021","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"10.14283\/jpad.2024.26_bib41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"10.14283\/jpad.2024.26_bib42","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-180766","article-title":"Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options","volume":"67","author":"Cummings","year":"2019","journal-title":"J Alzheimers Dis JAD"},{"key":"10.14283\/jpad.2024.26_bib43","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-190197","article-title":"Lithium as a Treatment for Alzheimer's Disease: The Systems Pharmacology Perspective","volume":"69","author":"Hampel","year":"2019","journal-title":"J Alzheimers Dis JAD"},{"key":"10.14283\/jpad.2024.26_bib44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat Rev Neurol"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T18:36:47Z","timestamp":1736447807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724000906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2274580724000906"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2024.26","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanolithium, a New Treatment Approach to Alzheimer's Disease: A Review of Existing Evidence and Clinical Perspectives","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2024.26","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}